NEWS

August 6, 2024

HealthCare Royalty and Blue Owl Announce $250M Debt Financing with TG Therapeutics

July 23, 2024

Valinor Pharma Announces Acquisition by Grünenthal with a Total Deal Value of Approximately $250 Million

July 22, 2024

Grünenthal acquires US-company Valinor Pharma and becomes global owner of Movantik®

July 18, 2024

OPKO Health and HealthCare Royalty Enter into $250 Million Note Purchase Agreement Secured by NGENLA’s Profit Share Payments

May 8, 2024

Karyopharm Announces Significant Refinancing Transactions and Amended Royalty Agreement Extending Vast Majority of Its Debt Maturities into 2028 and 2029

April 10, 2024

Zevra Therapeutics Refinances Existing Debt With Up To $100M In Committed Capital Under New Credit Facility

March 4, 2024

Heidelberg Pharma Announces Royalty Financing Agreement with HealthCare Royalty for up to USD 115 million

January 4, 2024

Liquidia Corporation Announces $100 Million in New Financings

January 3, 2024

HealthCare Royalty Announces Closing of Additional Debt Focused Fund, Team Expansion, and Promotions

November 2, 2023

Cara Therapeutics Announces up to $40.0 Million Non-Dilutive Financing Agreement with HealthCare Royalty